Protein kinase A-dependent stimulation of rat type II secreted phospholipase A2 gene transcription involves C/EBP-β and -δ in vascular smooth muscle cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 12, 2000, Pages 2559-2565

  Couturier, Cyril ^a   Antonio, Valérie ^a   Brouillet, Arthur ^a   Béréziat, Gilbert ^a   Raymondjean, Michel ^a   Andréani, Marise ^a  

^a SORBONNE UNIVERSITÉ   (France)

Author keywords

C EBP; Gene regulation; Protein kinase A; Smooth muscle cells

Indexed keywords

BUCLADESINE; CCAAT ENHANCER BINDING PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; MESSENGER RNA; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHOSPHOLIPASE A2;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CONSENSUS SEQUENCE; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; ENZYME ACTIVATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TANDEM REPEAT; VASCULAR SMOOTH MUSCLE;

EID: 0033664602     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.12.2559     Document Type: Article

References (39)

1. Secretory group II phospholipase A2 in human atherosclerotic plaques
2. Role of group II secretory phospholipase A2 in atherosclerosis, I: Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2
3. Cytokine-stimulated secretion of group II phospholipase A2 by rat mesangial cells: Its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomerular cells
4. Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cells: Evidence for release of fibroblast growth factor-2
5. Involvement of cyclooxygenase- and lipoxygenase-mediated conversion of arachidonic acid in controlling human vascular smooth muscle cell proliferation
6. Cytosolic 85-kDa phospholipase A2-mediated release of arachidonic acid is critical for proliferation of vascular smooth muscle cells
7. Cell biology of atherosclerosis
8. Localization of PDGF-B protein in macrophages in all phases of atherogenesis
9. Cytokines and smooth muscle cells in atherosclerosis
10. Group II phospholipase A2 mRNA synthesis is stimulated by two distinct mechanisms in rat vascular smooth muscle cells
11. A cluster of phosphorylation sites on the cyclic AMP-regulated nuclear factor CREB predicted by its sequence
12. C/EBP factor suppression of inhibition of type II secreted phospholipase A2 promoter in HepG2 cells: Possible role of single-strand binding proteins
13. Biological role of the CCAAT/enhancer-binding protein family of transcription factors
14. Selective isolation of rat aortic wall layers and their cell types in culture: Application to converting enzyme activity measurement
15. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
16. Interleukin 1β induces type-II-secreted phospholipase A2 gene in vascular smooth muscle cells by a nuclear factor κB and peroxisome proliferator-activated receptor-mediated process
17. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nucleic
18. Suppression by cyclosporin A of interleukin 1 beta-induced expression of group II phospholipase A2 in rat renal mesangial cells
19. The growing phospholipase A2 superfamily of signal transduction enzymes
20. Ultrastructural localization of secretory type II phospholipase A2 in atherosclerotic and nonatherosclerotic regions of human arteries
21. Secretory phospholipase A2 and lipoprotein lipase enhance 15-lipoxygenase-induced enzymic and nonenzymic lipid peroxidation in low-density lipoproteins
22. Expression of phospholipase A2 isoforms in human normal and atherosclerotic arterial wall
23. Down regulation by prostaglandins of type-II phospholipase A2 expression in guinea-pig alveolar macrophages: A possible involvement of cAMP
24. Ligand-independent activation of the glucocorticoid receptor by β2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells
25. COX-2 and cytosolic PLA2 mediate IL-1beta-induced cAMP production in human vascular smooth muscle cells
26. Adenylyl cyclase isoforms and vasopressin enhancement of agonist-stimulated cAMP in vascular smooth muscle cells
27. Angiotensin receptor subtype I mediates angiotensin II enhancement of isoproterenol-induced cyclic AMP production in preglomerular microvascular smooth muscle cells
28. Aldosterone, not estradiol, is the physiological agonist for rapid increases in cAMP in vascular smooth muscle cells
29. Regulation of vascular endothelial growth factor expression by cAMP in rat aortic smooth muscle cells
30. Structure of genomic DNA for rat platelet phospholipase A2
31. Isoform-specific regulation of the CCAAT/enhancer-binding protein family of transcription factors by 3[prime], 5[prime]-cyclic adenosine monophosphate in Sertoli cells
32. CREB controls LAP/CEBP beta transcription
33. C/EBP beta in rheumatoid arthritis: Correlation with inflammation not disease specificity
34. Complexes containing activating transcription factor (ATF)/cAMP-responsiveelement-binding protein (CREB) interact with the CCAAT/enhancer-binding protein (C/EBP)-ATF composite site to regulate Gadd153 expression during the stress response
35. The mechanism of transcriptional synergy of an in vitro assembled interferon-beta enhanceosome
36. Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription
37. Regulation of transcription factor C/ATF by the cAMP signal activation in hippocampal neurons, and molecular interaction of C/ATF with signal integrator CBP/P300
38. Interaction and functional collaboration of p300 and C/EBP beta
39. A high of CCAAT-enhancer binding protein delta expression is a major determinant for markedly elevated differential gene expression of the platelet-derived growth factor-alpha receptor in vascular smooth muscle cells of genetically hypertensive rats